These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24790989)

  • 1. Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.
    Mak A; Kow NY
    Biomed Res Int; 2014; 2014():178721. PubMed ID: 24790989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular damage in systemic lupus erythematosus.
    Ambler WG; Kaplan MJ
    Nat Rev Nephrol; 2024 Apr; 20(4):251-265. PubMed ID: 38172627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.
    Ding X; Xiang W; He X
    Front Immunol; 2020; 11():581385. PubMed ID: 33262760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities.
    Mauro D; Nerviani A
    Rev Recent Clin Trials; 2018; 13(3):192-198. PubMed ID: 29542419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation.
    Patiño-Trives AM; Pérez-Sánchez C; Pérez-Sánchez L; Luque-Tévar M; Ábalos-Aguilera MC; Alcaide-Ruggiero L; Arias-de la Rosa I; Román-Rodríguez C; Seguí P; Espinosa M; Font P; Barbarroja N; Escudero-Contreras A; Antonio González-Reyes J; Manuel Villalba J; Collantes-Estévez E; Aguirre-Zamorano MÁ; López-Pedrera C
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2417-2430. PubMed ID: 34320837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2.
    Carmona-Rivera C; Zhao W; Yalavarthi S; Kaplan MJ
    Ann Rheum Dis; 2015 Jul; 74(7):1417-24. PubMed ID: 24570026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in systemic lupus erythematosus: A comprehensive update.
    Giannelou M; Mavragani CP
    J Autoimmun; 2017 Aug; 82():1-12. PubMed ID: 28606749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index.
    Palmieri V; Migliaresi P; Orefice M; Lupo T; Di Minno MN; Valentini G; Celentano A
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):234-40. PubMed ID: 19157818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature vascular damage in systemic lupus erythematosus.
    Kaplan MJ
    Autoimmunity; 2009 Nov; 42(7):580-6. PubMed ID: 19657770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis.
    Thacker SG; Zhao W; Smith CK; Luo W; Wang H; Vivekanandan-Giri A; Rabquer BJ; Koch AE; Pennathur S; Davidson A; Eitzman DT; Kaplan MJ
    Arthritis Rheum; 2012 Sep; 64(9):2975-85. PubMed ID: 22549550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
    Liu Y; Yu X; Zhang W; Zhang X; Wang M; Ji F
    J Autoimmun; 2022 Oct; 132():102863. PubMed ID: 35853760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endothelial dysfunction in patients with systemic lupus erythematosus].
    Serikova SIu; Kozlovskaia NL; Shilov EM
    Ter Arkh; 2010; 82(2):70-4. PubMed ID: 20387683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.
    Mak A; Chan JKY
    Nat Rev Rheumatol; 2022 May; 18(5):286-300. PubMed ID: 35393604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.
    Attia FM; Maaty A; Kalil FA
    Arch Pathol Lab Med; 2011 Nov; 135(11):1482-5. PubMed ID: 22032577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature vascular damage in systemic lupus erythematosus: an imbalance of damage and repair?
    Kaplan MJ
    Transl Res; 2009 Aug; 154(2):61-9. PubMed ID: 19595437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD].
    Tani C; Mosca M; d'Ascanio A; Versari D; Virdis A; Ghiadoni L; Taddei S; Salvetti A; Bombardieri S
    Reumatismo; 2006; 58(3):212-8. PubMed ID: 17013438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.
    Kahlenberg JM; Thacker SG; Berthier CC; Cohen CD; Kretzler M; Kaplan MJ
    J Immunol; 2011 Dec; 187(11):6143-56. PubMed ID: 22058412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cells: a new player in lupus?
    Haque S; Alexander MY; Bruce IN
    Arthritis Res Ther; 2012 Feb; 14(1):203. PubMed ID: 22356717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune mechanisms associated with cardiovascular disease in systemic lupus erythematosus: A path to potential biomarkers.
    Guzmán-Martínez G; Marañón C;
    Front Immunol; 2022; 13():974826. PubMed ID: 36420265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction and cardiovascular risk in lupus nephritis: New roles for old players?
    Mancardi D; Arrigo E; Cozzi M; Cecchi I; Radin M; Fenoglio R; Roccatello D; Sciascia S
    Eur J Clin Invest; 2021 Feb; 51(2):e13441. PubMed ID: 33128260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.